CorridorAcquisition InformationforInvestor VF
CorridorAcquisition InformationforInvestor VF
CorridorAcquisition InformationforInvestor VF
Credit Strengths:
• The acquisition consolidates Medco as the main piped gas supplier to Singapore.
• Improved operating scale with long-term offtake and Take or Pay backed contracts with high quality
counterparties (PGN, Pertamina and GSPL).
• Corridor’s cash cost of US$4-5/boe will support Medco’s cash cost sub US$10/boe commitment.
• Corridor is adjacent to Medco’s existing operations in South Sumatra and the combined portfolio will
generate operational, procurement and commercial synergies.
• Regular dividends from Transasia.
• Restricted Group and Total Debt will increase post acquisition, but the 37% equity contribution and strong
cash generation will enable our leverage to come back to pre acquisition levels by 2023-24.
2
Target Overview
Thailand Laos
Bualuang
Vietnam
Cambodia
Sulawesi
South
Sumatra
Region Senoro-Toili Papua Papua
Sumatra IPP Sampang Madura New
Batu Hijau Guinea
Java Elang
Production
Production Development Mining Production Mining Development
Power Installed Power Development
4 Exploration Mining Exploration
Corridor Block PSC – Asset Overview
Block awarded in 1983, PSC cost recovery will expire in December 2023.
Block extended from Dec 2023 - Dec 2043 under PSC gross split terms.
To Pertamina Rokan GSA with Pertamina Current Partnership:
and PGN Dumai o CPGL 54% (Operator)
o Repsol (Corridor) Ltd. 36%
o Pertamina Hulu Energi Corridor 10%
5
PT Transportasi Gas Indonesia (TGI) – Asset Overview
ConocoPhillips
Petronas Repsol SPC
Indonesia Holding Ltd
PT Transportasi
Gas Indonesia
Pipelines
• Grissik – Duri: 28” pipeline 536 km onshore, 427 mmscfd
• Grissik – Singapore: 28” pipeline 220 km onshore, 248 km offshore, 465 mmscfd
Financial
• TGI has consistently paid dividends to Shareholders since 2011
6
Acquisition Timeline
EGMS EGMS Invitation EGMS
Announcement Early Feb 22 End Feb 22
Mid Jan 22
Full payment to Seller
Agreement Signing Rights Issue
SPA Closing Date
Date Proceeds
Early Mar 22
Early Dec 21 End Mar 22
The Transaction is expected to complete in March 2022, subject to customary conditions and shareholders’ approval at an Extraordinary
General Meeting of Shareholders (“EGMS”).
Shareholders approved a Rights Issue in August 2021 to fund an acquisition. This is expected to be executed Q1 2022 subject to regulatory
approvals.
690
645
525
382 369 400
142
55
2021 2022 2023 2024 2025 2026 2027 2028
9
2022 Guidance: Expenditure
9M-2021 Actual
Cash Cost/Unit(2), US$/boe
• Oil & Gas Capex US$31mn. Activities ramping up but
155
will be under full year guidance of US$150mn
103 100
• Power1 US$22mn, to progress Riau Project 87 85 93
66
commissioning. Expect to be under full year 56 56
guidance of US$65mn due to project re-phasing 15.4
12.3
9.1 9.9 9.1 9.3 <10
• Oil & Gas cash costs US$9.3/boe, notwithstanding 8.8 8.4
extended shutdowns in Q2.
2014 2015 2016 2017 2018 2019 2020 9M21 2022
Pro forma
guidance
Cash Cost Production (mboepd)
Production1
1,125 1,171
Oil, MBOPD 40.6 35.0 (13.7)
Gas, MMSCFD 319.3 311.3 (2.5)
Lifting/Sales
Oil Lifting1, MBOPD 38.9 33.8 (13.2)
Gas Sales, BBTUPD 299.8 288.7 (3.7) 1,015 1,058
475
Oman Service Contract, MBOPD 7.6 7.2 (4.5)
310
Average Realized Price 321
163
Oil, USD/barrel 39.5 64.1 62.3
147 154 110 113
Gas, USD/MMBTU 5.1 6.3 23.2
ESG Indicators 1 Jan 2021 Pro forma Corridor 1 Jan 2021 Pro forma Corridor
2
Scope-1 Intensity (tCO2 eq/1,000 TOE Production) 216.7 212.9 (1.8) 1 Jan 2021 1 Jan 2021
Scope-1 Energy Consumption3 (in million GJ) 13.31 12.90 (3.1)
E&P Recordable Incident Rate (TRIR) 0.43 0.35 (18.6) Net Hydrocarbon Production1, MBOEPD Net Hydrocarbon Production1, MBOEPD
• 2020 5-year average 2P RRR 1.2x, 2020 2P RLI3 9.9 Years 22%
Website : www.medcoenergi.com